시타글립틴데푸오로IMpurity3
|
|
시타글립틴데푸오로IMpurity3 속성
- 끓는 점
- 444.3±45.0 °C(Predicted)
- 밀도
- 1.243±0.06 g/cm3(Predicted)
- 저장 조건
- 2-8°C
- 산도 계수 (pKa)
- 4.37±0.10(Predicted)
안전
- 위험 및 안전 성명
- 위험 및 사전주의 사항 (GHS)
그림문자(GHS): | ||||||||||||||||||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
신호 어: | Warning | |||||||||||||||||||||||||||||||||||
유해·위험 문구: |
|
|||||||||||||||||||||||||||||||||||
예방조치문구: |
|
시타글립틴데푸오로IMpurity3 C화학적 특성, 용도, 생산
시타글립틴데푸오로IMpurity3 준비 용품 및 원자재
원자재
Benzenebutanoic acid, β-[[(1S)-2-amino-2-oxo-1-phenylethyl]amino]-2,4-difluoro-, methyl ester, (βR)-
4-(2,4-디플루오로-페닐)-3-옥소-부틸산메틸에스테르
2,4-Difluorophenylacetic acid
2,4-디플루오로페닐아세트산
준비 용품
시타글립틴데푸오로IMpurity3 공급 업체
글로벌( 67)공급 업체
공급자 | 전화 | 이메일 | 국가 | 제품 수 | 이점 |
---|---|---|---|---|---|
Standardpharm Co. Ltd. | 86-714-3992388 |
overseasales1@yongstandards.com | United States | 14335 | 58 |
Allfluoro pharmaceutical co. ltd. | 021-26137118 +8615821363818 |
sales@allfluoro.com | China | 5791 | 58 |
Career Henan Chemica Co | +86-0371-86658258 +8613203830695 |
laboratory@coreychem.com | China | 30250 | 58 |
Hangzhou Huarong Pharm Co., Ltd. | 571-86758373 +8613588754946 |
sales@huarongpharm.com | CHINA | 3149 | 58 |
Hong Kong Tiansheng New Material Trading Co., Ltd | +8617320695765 |
zxx@hktiansheng.com | China | 981 | 58 |
China National Standard Pharmaceutical Corporation Limited | +8615391658522 |
overseasales@yongstandards.com | China | 11927 | 58 |
LEAPCHEM CO., LTD. | +86-852-30606658 |
market18@leapchem.com | China | 43348 | 58 |
Shanghai Acmec Biochemical Technology Co., Ltd. | +undefined18621343501 |
product@acmec-e.com | China | 33350 | 58 |
SHANGHAI KEAN TECHNOLOGY CO., LTD. | +8613817748580 |
cooperation@kean-chem.com | China | 40068 | 58 |
Amadis Chemical Company Limited | 571-89925085 |
sales@amadischem.com | China | 131980 | 58 |
시타글립틴데푸오로IMpurity3 관련 검색:
Methyl 3-Oxo-4-(2,4,5-trifluorophenyl)butanoate
Sitagliptin Impurity 14
1,2,4-Triazolo[4,3-a]pyrazine, 7-[3-amino-1-oxo-4-(2,4,5-trifluorophenyl)-2-butenyl]-5,6,7,8-tetrahydro- 3-(trifluoromethyl)-
(2Z)-4-Oxo-4-[3-(trifluoromethyl)-5,6-dihydro-[1,2,4]triazolo[4,3-a]pyrazine-7(8H)-yl]-1-(2,4,5-trifluorophenyl)butan-2-one
rac-Sitagliptin EP Impurity B HCl
Sitagliptin
Sitagliptin Impurity 28
Sitagliptin
Duloxetine N-DesMethyl Metabolite
7-[(3R)-3-[(N-Acetyl)AMino]-1-oxo-4-(2,4,5-trifluorophenyl)butyl]-5,6,7,8-tetrahydro-3-(trifluoroMethyl)-1,2,4-triazolo[4,3-a]pyrazine
Sitagliptin Defuoro IMpurity 4
(R)-10-(2,4,5-trifluorobenzyl)-3-(trifluoromethyl)-6,7,10,11-tetrahydro-[1,2,4]triazolo[3,4-c][1,4,7]triazecine-8,12(5H,9H)-dione
N'-[(2Z)-Piperazin-2-ylidene]trifluoroacetohydrazide
(S)-Duloxetine SuccinaMide
Methyl 3-aMino-4-(2,4,5-trifluorophenyl)butanoate
Sitagliptin phosphate monohydrate
2,4,5-Trifluorobenzaldehyde
Sitagliptin N-Phoshate IMpurity